Results 61 to 70 of about 88,381 (100)

PET imaging of PARP expression using 68Ga-labelled inhibitors. [PDF]

open access: yesEur J Nucl Med Mol Imaging, 2023
Wang X   +8 more
europepmc   +1 more source

[68Ga]Ga-NODAGA-E[(cRGDyK)]2 angiogenesis PET following myocardial infarction in an experimental rat model predicts cardiac functional parameters and development of heart failure. [PDF]

open access: yesJ Nucl Cardiol, 2023
Bentsen S   +12 more
europepmc   +1 more source

Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand. [PDF]

open access: yesEur J Nucl Med Mol Imaging, 2023
Derks YHW   +15 more
europepmc   +1 more source

Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression. [PDF]

open access: yesJ Nucl Med, 2023
Isser S   +8 more
europepmc   +1 more source

[<sup>89</sup>Zr]Zr-DFO-Trodelvy immunoPET for noninvasive Trop2 imaging in bladder cancer. [PDF]

open access: yesAm J Nucl Med Mol Imaging
Huang W   +9 more
europepmc   +1 more source

Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibody. [PDF]

open access: yesEur J Nucl Med Mol Imaging, 2023
Stergiou N   +15 more
europepmc   +1 more source

Recommendations for reporting preclinical radiobiological studies in targeted radionuclide therapy. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Mendes F   +6 more
europepmc   +1 more source

In vivo evaluation of a novel <sup>18</sup>F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain. [PDF]

open access: yesEur J Nucl Med Mol Imaging, 2023
Yan X   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy